Qura, a Milan-based health-tech startup developing an AI-powered preventive care platform, has raised €1.5 million in a pre-seed funding round led by United Ventures.
The round also included participation from Vento, Italian Angels for Growth (IAG), and several angel investors. The company plans to use the capital to expand its medical and engineering teams, enhance its AI capabilities, and prepare for broader European market entry.
What The Company Does
Founded by CEO Virginia Gambardella, Qura provides an integrated preventive healthcare pathway designed for individuals experiencing ongoing subclinical symptoms such as chronic fatigue, hormonal imbalances, digestive issues, or unexplained hair loss. These conditions often fall outside acute care frameworks but can significantly affect long-term wellbeing.
The platform combines comprehensive blood testing through partner laboratories with AI-driven analysis and a 45-minute consultation with a dedicated physician. Based on these inputs, users receive a personalised health plan that includes immediate recommendations and structured long-term monitoring.
Qura operates a hybrid care model in which physicians remain central to diagnosis and guidance, while AI supports data interpretation, efficiency, and personalisation. The platform is built as an EU-native, GDPR-compliant system aligned with medical standards and integrated into local laboratory networks.
Advertisement
Market Context / Industry Background
Preventive healthcare demand is increasing across Europe, with the health check-up market projected to reach €18.6 billion by 2030. Despite this growth, healthcare systems remain primarily oriented toward acute and emergency treatment, often leaving non-urgent but persistent conditions under-addressed.
Many individuals seeking preventive diagnostics or lifestyle-related health insights must rely on fragmented services or out-of-pocket payments. Limited consultation time in traditional primary care settings and lack of coordinated follow-up further contribute to gaps in preventive care delivery.
Digital health platforms combining diagnostics, AI-based insights, and structured medical oversight are emerging as a response to these structural limitations. Such models aim to improve early risk detection, increase patient adherence, and enable data-driven health management before conditions escalate into diagnosable illnesses.
Founder / Investor Commentary
CEO Virginia Gambardella stated that healthcare systems frequently treat health concerns only once they reach emergency thresholds, leaving many individuals without clear guidance when symptoms first emerge. She emphasized that Qura’s model integrates AI precision with physician-led care to support proactive health management rather than reactive treatment.
Investors highlighted the structural opportunity within preventive healthcare, particularly as consumers increasingly seek personalised, data-driven insights while maintaining clinical oversight and regulatory compliance.
Growth Plans / Use Of Funds
The €1.5 million in new funding will support hiring across medical, engineering, and operations teams, as well as investments in digital marketing and community-led growth initiatives. Qura also plans to further develop its AI health intelligence engine to improve diagnostic support and personalised recommendation systems.
In parallel, the company is preparing for expansion into additional European markets, building on its EU-native infrastructure and laboratory partnerships to scale preventive healthcare services across the region.
About Qura
Qura is a Milan-based health-tech platform providing AI-enabled preventive healthcare services. The company integrates laboratory diagnostics, personalised AI analysis, and physician-led consultations to help individuals identify and manage health risks before they develop into acute conditions, promoting data-driven and proactive wellbeing across Europe.
